tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Allergy Therapeutics Advances Phase III Trial for Paediatric Grass Allergy Treatment
Company AnnouncementsAllergy Therapeutics Advances Phase III Trial for Paediatric Grass Allergy Treatment
5d ago
Allergy Therapeutics Strengthens Financial Position with New Loan Facility
PremiumCompany Announcements
Allergy Therapeutics Strengthens Financial Position with New Loan Facility
6d ago
Allergy Therapeutics Advances Peanut Allergy Vaccine with Positive Trial Results
PremiumCompany Announcements
Allergy Therapeutics Advances Peanut Allergy Vaccine with Positive Trial Results
19d ago
Allergy Therapeutics’ VLP Peanut Trial: A Potential Game-Changer for Peanut Allergy Treatment
PremiumCompany Announcements
Allergy Therapeutics’ VLP Peanut Trial: A Potential Game-Changer for Peanut Allergy Treatment
2M ago
AGY
Allergy Therapeutics Advances VLP Peanut Study: A Potential Breakthrough in Allergy Treatment
PremiumCompany Announcements
Allergy Therapeutics Advances VLP Peanut Study: A Potential Breakthrough in Allergy Treatment
3M ago
Allergy Therapeutics Strengthens Evidence for Grass MATA MPL Immunotherapy
PremiumCompany AnnouncementsAllergy Therapeutics Strengthens Evidence for Grass MATA MPL Immunotherapy
3M ago
Allergy Therapeutics Maintains Stable Performance Amid Strategic Growth Initiatives
Premium
Company Announcements
Allergy Therapeutics Maintains Stable Performance Amid Strategic Growth Initiatives
4M ago
Allergy Therapeutics Issues Over 250 Million Warrants Amid Financial Strategy
Premium
Company Announcements
Allergy Therapeutics Issues Over 250 Million Warrants Amid Financial Strategy
4M ago
Allergy Therapeutics Unveils Promising Research at EAACI 2025
PremiumCompany Announcements
Allergy Therapeutics Unveils Promising Research at EAACI 2025
5M ago
Allergy Therapeutics and EAACI Honor Early Career Researcher
PremiumCompany Announcements
Allergy Therapeutics and EAACI Honor Early Career Researcher
5M ago
Allergy Therapeutics Reports Financial Turnaround and Clinical Progress
PremiumCompany Announcements
Allergy Therapeutics Reports Financial Turnaround and Clinical Progress
7M ago
Allergy Therapeutics Advances Peanut Allergy Vaccine Trial to Final Phase
PremiumCompany Announcements
Allergy Therapeutics Advances Peanut Allergy Vaccine Trial to Final Phase
7M ago
Allergy Therapeutics Announces New Incentive Awards to Boost Growth
PremiumCompany AnnouncementsAllergy Therapeutics Announces New Incentive Awards to Boost Growth
8M ago
Allergy Therapeutics Showcases Research at 2025 AAAAI/WAO Congress
Premium
Company Announcements
Allergy Therapeutics Showcases Research at 2025 AAAAI/WAO Congress
8M ago
Allergy Therapeutics’ Grass MATA MPL Shows Promising Phase III Results
Premium
Company Announcements
Allergy Therapeutics’ Grass MATA MPL Shows Promising Phase III Results
9M ago
Allergy Therapeutics Grants Share Options to Drive Long-Term Growth
PremiumCompany Announcements
Allergy Therapeutics Grants Share Options to Drive Long-Term Growth
9M ago
Allergy Therapeutics Reports Financial Turnaround and Advances in Allergy Treatments
PremiumCompany Announcements
Allergy Therapeutics Reports Financial Turnaround and Advances in Allergy Treatments
9M ago
Allergy Therapeutics Announces Share Transactions and Voting Rights Update
PremiumCompany Announcements
Allergy Therapeutics Announces Share Transactions and Voting Rights Update
10M ago
Allergy Therapeutics Issues 687.5 Million Warrants to Bolster Financial Strategy
PremiumCompany Announcements
Allergy Therapeutics Issues 687.5 Million Warrants to Bolster Financial Strategy
10M ago
Allergy Therapeutics Rectifies Share Option Oversight
PremiumCompany AnnouncementsAllergy Therapeutics Rectifies Share Option Oversight
11M ago
Allergy Therapeutics Shows Promising Results for Peanut Allergy
Premium
Company Announcements
Allergy Therapeutics Shows Promising Results for Peanut Allergy
11M ago
Allergy Therapeutics Begins Innovative Paediatric Allergy Trial
Premium
Company Announcements
Allergy Therapeutics Begins Innovative Paediatric Allergy Trial
11M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >